CELZ Stock Overview
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 5/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Creative Medical Technology Holdings, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$5.36 |
52 Week High | US$13.30 |
52 Week Low | US$3.93 |
Beta | 4.95 |
1 Month Change | 23.22% |
3 Month Change | 14.78% |
1 Year Change | 11.67% |
3 Year Change | -97.37% |
5 Year Change | -99.92% |
Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
CELZ | US Biotechs | US Market | |
---|---|---|---|
7D | -14.2% | -2.3% | -0.3% |
1Y | 11.7% | 11.5% | 29.4% |
Return vs Industry: CELZ exceeded the US Biotechs industry which returned 10.2% over the past year.
Return vs Market: CELZ underperformed the US Market which returned 28.4% over the past year.
Price Volatility
CELZ volatility | |
---|---|
CELZ Average Weekly Movement | 12.0% |
Biotechs Industry Average Movement | 12.0% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.8% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CELZ has not had significant price volatility in the past 3 months.
Volatility Over Time: CELZ's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 4 | Tim Warbington | https://www.creativemedicaltechnology.com |
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
Creative Medical Technology Holdings, Inc. Fundamentals Summary
CELZ fundamental statistics | |
---|---|
Market cap | US$7.17m |
Earnings (TTM) | -US$9.82m |
Revenue (TTM) | US$24.60k |
301.1x
P/S Ratio-0.8x
P/E RatioIs CELZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CELZ income statement (TTM) | |
---|---|
Revenue | US$24.60k |
Cost of Revenue | US$8.10k |
Gross Profit | US$16.50k |
Other Expenses | US$9.84m |
Earnings | -US$9.82m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -7.11 |
Gross Margin | 67.07% |
Net Profit Margin | -39,933.71% |
Debt/Equity Ratio | 0.1% |
How did CELZ perform over the long term?
See historical performance and comparison